Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for EPAS1_BCL3
Z-value: 3.67
Motif logo
Transcription factors associated with EPAS1_BCL3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EPAS1
|
ENSG00000116016.9 | endothelial PAS domain protein 1 |
|
BCL3
|
ENSG00000069399.8 | BCL3 transcription coactivator |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| EPAS1 | hg19_v2_chr2_+_46524537_46524553 | 0.64 | 7.2e-05 | Click! |
| BCL3 | hg19_v2_chr19_+_45254529_45254578 | -0.36 | 4.2e-02 | Click! |
Activity profile of EPAS1_BCL3 motif
Sorted Z-values of EPAS1_BCL3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_116163830 | 11.95 |
ENST00000333617.4
|
LSAMP
|
limbic system-associated membrane protein |
| chr19_+_35629702 | 8.57 |
ENST00000351325.4
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr7_+_136553370 | 7.23 |
ENST00000445907.2
|
CHRM2
|
cholinergic receptor, muscarinic 2 |
| chr7_+_154002527 | 6.93 |
ENST00000427557.1
|
DPP6
|
dipeptidyl-peptidase 6 |
| chr2_-_170219037 | 6.70 |
ENST00000443831.1
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chr7_-_128001658 | 6.50 |
ENST00000489835.2
ENST00000464607.1 ENST00000489517.1 ENST00000446477.2 ENST00000535159.1 ENST00000435512.1 ENST00000495931.1 |
PRRT4
|
proline-rich transmembrane protein 4 |
| chr12_+_121088291 | 6.18 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
| chr10_-_30348439 | 6.09 |
ENST00000375377.1
|
KIAA1462
|
KIAA1462 |
| chr1_+_86046433 | 6.07 |
ENST00000451137.2
|
CYR61
|
cysteine-rich, angiogenic inducer, 61 |
| chr7_+_121513374 | 6.05 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr7_+_154002189 | 5.96 |
ENST00000332007.3
|
DPP6
|
dipeptidyl-peptidase 6 |
| chr19_+_30863271 | 5.95 |
ENST00000355537.3
|
ZNF536
|
zinc finger protein 536 |
| chr7_+_73442487 | 5.89 |
ENST00000380575.4
ENST00000380584.4 ENST00000458204.1 ENST00000357036.5 ENST00000417091.1 ENST00000429192.1 ENST00000442310.1 ENST00000380553.4 ENST00000380576.5 ENST00000428787.1 ENST00000320399.6 |
ELN
|
elastin |
| chr15_+_40643227 | 5.66 |
ENST00000448599.2
|
PHGR1
|
proline/histidine/glycine-rich 1 |
| chr15_+_74466012 | 5.49 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
| chr19_-_35626104 | 5.49 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr11_-_70507867 | 5.46 |
ENST00000412252.1
ENST00000409161.1 ENST00000409530.1 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
| chr20_+_34680698 | 5.46 |
ENST00000447825.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr14_+_42077552 | 5.35 |
ENST00000554120.1
|
LRFN5
|
leucine rich repeat and fibronectin type III domain containing 5 |
| chr3_-_142608001 | 5.34 |
ENST00000295992.3
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
| chr3_-_58572760 | 5.33 |
ENST00000447756.2
|
FAM107A
|
family with sequence similarity 107, member A |
| chr19_+_7660716 | 5.32 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr11_+_19798964 | 5.32 |
ENST00000527559.2
|
NAV2
|
neuron navigator 2 |
| chr4_-_186732048 | 5.27 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr20_+_34680620 | 5.23 |
ENST00000430276.1
ENST00000373950.2 ENST00000452261.1 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr5_+_122424816 | 5.23 |
ENST00000407847.4
|
PRDM6
|
PR domain containing 6 |
| chr3_-_142607740 | 5.17 |
ENST00000485766.1
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
| chr7_-_140340098 | 5.16 |
ENST00000477488.1
|
DENND2A
|
DENN/MADD domain containing 2A |
| chr12_-_86230315 | 5.13 |
ENST00000361228.3
|
RASSF9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
| chr3_-_187009646 | 5.13 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr17_+_8213590 | 5.08 |
ENST00000361926.3
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
| chr5_+_6448736 | 5.01 |
ENST00000399816.3
|
UBE2QL1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
| chrX_-_20134990 | 4.88 |
ENST00000379651.3
ENST00000443379.3 ENST00000379643.5 |
MAP7D2
|
MAP7 domain containing 2 |
| chr15_+_48009541 | 4.85 |
ENST00000536845.2
ENST00000558816.1 |
SEMA6D
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
| chr9_+_87283430 | 4.55 |
ENST00000376214.1
ENST00000376213.1 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr7_+_136553824 | 4.47 |
ENST00000320658.5
ENST00000453373.1 ENST00000397608.3 ENST00000402486.3 ENST00000401861.1 |
CHRM2
|
cholinergic receptor, muscarinic 2 |
| chr20_+_34680595 | 4.45 |
ENST00000406771.2
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr4_-_5894777 | 4.45 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
| chr19_-_35625765 | 4.45 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr22_+_42372970 | 4.30 |
ENST00000291236.11
|
SEPT3
|
septin 3 |
| chr22_+_41956767 | 4.28 |
ENST00000306149.7
|
CSDC2
|
cold shock domain containing C2, RNA binding |
| chr16_-_70719925 | 4.26 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
| chr1_-_21978312 | 4.25 |
ENST00000359708.4
ENST00000290101.4 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr8_+_69242957 | 4.22 |
ENST00000518698.1
ENST00000539993.1 |
C8orf34
|
chromosome 8 open reading frame 34 |
| chr18_+_32290218 | 4.16 |
ENST00000348997.5
ENST00000588949.1 ENST00000597599.1 |
DTNA
|
dystrobrevin, alpha |
| chr7_+_73442422 | 4.13 |
ENST00000358929.4
ENST00000431562.1 ENST00000320492.7 ENST00000438906.1 |
ELN
|
elastin |
| chr3_-_168865522 | 4.12 |
ENST00000464456.1
|
MECOM
|
MDS1 and EVI1 complex locus |
| chr20_+_10199468 | 4.10 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
| chr7_+_95401851 | 4.09 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr20_+_17207636 | 4.09 |
ENST00000262545.2
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
| chr2_-_67442409 | 4.06 |
ENST00000414404.1
ENST00000433133.1 |
AC078941.1
|
AC078941.1 |
| chr2_-_56150910 | 3.99 |
ENST00000424836.2
ENST00000438672.1 ENST00000440439.1 ENST00000429909.1 ENST00000424207.1 ENST00000452337.1 ENST00000355426.3 ENST00000439193.1 ENST00000421664.1 |
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
| chr12_+_50451462 | 3.98 |
ENST00000447966.2
|
ASIC1
|
acid-sensing (proton-gated) ion channel 1 |
| chr1_-_44497024 | 3.94 |
ENST00000372306.3
ENST00000372310.3 ENST00000475075.2 |
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr11_-_70507901 | 3.92 |
ENST00000449833.2
ENST00000357171.3 ENST00000449116.2 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
| chr1_-_234667504 | 3.89 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
| chr22_+_42372764 | 3.89 |
ENST00000396426.3
ENST00000406029.1 |
SEPT3
|
septin 3 |
| chr11_+_111807863 | 3.86 |
ENST00000440460.2
|
DIXDC1
|
DIX domain containing 1 |
| chr20_+_43343476 | 3.85 |
ENST00000372868.2
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr1_+_218519577 | 3.84 |
ENST00000366930.4
ENST00000366929.4 |
TGFB2
|
transforming growth factor, beta 2 |
| chr17_+_21279509 | 3.81 |
ENST00000583088.1
|
KCNJ12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
| chr8_-_33455268 | 3.80 |
ENST00000522982.1
|
DUSP26
|
dual specificity phosphatase 26 (putative) |
| chr7_+_73442457 | 3.76 |
ENST00000438880.1
ENST00000414324.1 ENST00000380562.4 |
ELN
|
elastin |
| chr8_-_61193947 | 3.73 |
ENST00000317995.4
|
CA8
|
carbonic anhydrase VIII |
| chr2_+_56411131 | 3.69 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
| chr12_-_16761007 | 3.69 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr4_-_154710210 | 3.67 |
ENST00000274063.4
|
SFRP2
|
secreted frizzled-related protein 2 |
| chr5_+_169931009 | 3.67 |
ENST00000328939.4
ENST00000390656.4 |
KCNIP1
|
Kv channel interacting protein 1 |
| chr5_-_142000883 | 3.66 |
ENST00000359370.6
|
FGF1
|
fibroblast growth factor 1 (acidic) |
| chrX_+_102585124 | 3.65 |
ENST00000332431.4
ENST00000372666.1 |
TCEAL7
|
transcription elongation factor A (SII)-like 7 |
| chr20_+_17207665 | 3.63 |
ENST00000536609.1
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2 |
| chr14_+_79745682 | 3.63 |
ENST00000557594.1
|
NRXN3
|
neurexin 3 |
| chr1_+_22970119 | 3.55 |
ENST00000374640.4
ENST00000374639.3 ENST00000374637.1 |
C1QC
|
complement component 1, q subcomponent, C chain |
| chr8_+_68864330 | 3.55 |
ENST00000288368.4
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
| chr11_+_19799327 | 3.53 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
| chr9_+_69650263 | 3.53 |
ENST00000322495.3
|
AL445665.1
|
Protein LOC100996643 |
| chr20_+_9049682 | 3.51 |
ENST00000334005.3
ENST00000378473.3 |
PLCB4
|
phospholipase C, beta 4 |
| chr7_-_14942467 | 3.49 |
ENST00000407950.1
ENST00000444700.2 |
DGKB
|
diacylglycerol kinase, beta 90kDa |
| chr7_+_121513143 | 3.48 |
ENST00000393386.2
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr22_+_42372931 | 3.46 |
ENST00000328414.8
ENST00000396425.3 |
SEPT3
|
septin 3 |
| chr4_-_168155417 | 3.43 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr11_+_43964055 | 3.42 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
| chr9_-_14910990 | 3.41 |
ENST00000380881.4
ENST00000422223.2 |
FREM1
|
FRAS1 related extracellular matrix 1 |
| chr12_+_15125954 | 3.40 |
ENST00000266395.2
|
PDE6H
|
phosphodiesterase 6H, cGMP-specific, cone, gamma |
| chr19_+_35630344 | 3.39 |
ENST00000455515.2
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr3_-_195310802 | 3.39 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr2_-_56150184 | 3.38 |
ENST00000394554.1
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
| chr4_-_168155577 | 3.35 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr19_-_47975417 | 3.35 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr4_-_186732892 | 3.34 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr2_+_14772810 | 3.33 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr11_+_1430629 | 3.32 |
ENST00000528596.1
|
BRSK2
|
BR serine/threonine kinase 2 |
| chrX_-_99665262 | 3.31 |
ENST00000373034.4
ENST00000255531.7 |
PCDH19
|
protocadherin 19 |
| chr3_-_134093275 | 3.30 |
ENST00000513145.1
ENST00000422605.2 |
AMOTL2
|
angiomotin like 2 |
| chr11_-_89224488 | 3.29 |
ENST00000534731.1
ENST00000527626.1 |
NOX4
|
NADPH oxidase 4 |
| chr16_+_22825475 | 3.26 |
ENST00000261374.3
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
| chr20_-_2781222 | 3.24 |
ENST00000380605.2
|
CPXM1
|
carboxypeptidase X (M14 family), member 1 |
| chr5_-_142065223 | 3.24 |
ENST00000378046.1
|
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr12_+_50451331 | 3.22 |
ENST00000228468.4
|
ASIC1
|
acid-sensing (proton-gated) ion channel 1 |
| chr3_-_184870751 | 3.21 |
ENST00000335012.2
|
C3orf70
|
chromosome 3 open reading frame 70 |
| chr7_+_95401877 | 3.20 |
ENST00000524053.1
ENST00000324972.6 ENST00000537881.1 ENST00000437599.1 ENST00000359388.4 ENST00000413338.1 |
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr3_-_133748758 | 3.19 |
ENST00000493729.1
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1 |
| chr7_+_114055052 | 3.15 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
| chr22_-_36236623 | 3.14 |
ENST00000405409.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr16_-_66959429 | 3.14 |
ENST00000420652.1
ENST00000299759.6 |
RRAD
|
Ras-related associated with diabetes |
| chr17_+_64961026 | 3.12 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
| chr22_-_36236265 | 3.11 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr9_+_34652164 | 3.10 |
ENST00000441545.2
ENST00000553620.1 |
IL11RA
|
interleukin 11 receptor, alpha |
| chr9_+_103790991 | 3.08 |
ENST00000374874.3
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
| chrX_-_74742846 | 3.07 |
ENST00000373361.3
|
ZDHHC15
|
zinc finger, DHHC-type containing 15 |
| chr17_+_73750699 | 3.06 |
ENST00000584939.1
|
ITGB4
|
integrin, beta 4 |
| chr16_+_82068830 | 3.04 |
ENST00000199936.4
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr11_-_61348292 | 3.04 |
ENST00000539008.1
ENST00000540677.1 ENST00000542836.1 ENST00000542670.1 ENST00000535826.1 ENST00000545053.1 |
SYT7
|
synaptotagmin VII |
| chr2_+_102686820 | 3.03 |
ENST00000409929.1
ENST00000424272.1 |
IL1R1
|
interleukin 1 receptor, type I |
| chr4_-_168155700 | 3.02 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr1_+_157963063 | 3.01 |
ENST00000360089.4
ENST00000368173.3 ENST00000392272.2 |
KIRREL
|
kin of IRRE like (Drosophila) |
| chr16_+_6069072 | 3.01 |
ENST00000547605.1
ENST00000550418.1 ENST00000553186.1 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr2_-_170219079 | 2.99 |
ENST00000263816.3
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chr3_-_73483055 | 2.98 |
ENST00000479530.1
|
PDZRN3
|
PDZ domain containing ring finger 3 |
| chr10_+_123923205 | 2.98 |
ENST00000369004.3
ENST00000260733.3 |
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr19_+_35630022 | 2.97 |
ENST00000589209.1
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr10_+_88414338 | 2.97 |
ENST00000241891.5
ENST00000443292.1 |
OPN4
|
opsin 4 |
| chr17_-_53809473 | 2.97 |
ENST00000575734.1
|
TMEM100
|
transmembrane protein 100 |
| chr4_-_175041663 | 2.95 |
ENST00000503140.1
|
RP11-148L24.1
|
RP11-148L24.1 |
| chr1_-_177133818 | 2.95 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
| chr4_+_62067860 | 2.93 |
ENST00000514591.1
|
LPHN3
|
latrophilin 3 |
| chr17_+_71161140 | 2.91 |
ENST00000357585.2
|
SSTR2
|
somatostatin receptor 2 |
| chr19_-_47975106 | 2.91 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr8_-_89339705 | 2.91 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
| chr8_-_110620284 | 2.88 |
ENST00000529690.1
|
SYBU
|
syntabulin (syntaxin-interacting) |
| chr11_-_89224299 | 2.88 |
ENST00000343727.5
ENST00000531342.1 ENST00000375979.3 |
NOX4
|
NADPH oxidase 4 |
| chr4_+_158141806 | 2.88 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr16_-_31147020 | 2.87 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
| chr2_+_36923901 | 2.86 |
ENST00000457137.2
|
VIT
|
vitrin |
| chr9_+_87284675 | 2.85 |
ENST00000376208.1
ENST00000304053.6 ENST00000277120.3 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
| chr14_+_42076765 | 2.85 |
ENST00000298119.4
|
LRFN5
|
leucine rich repeat and fibronectin type III domain containing 5 |
| chr6_+_74405501 | 2.84 |
ENST00000437994.2
ENST00000422508.2 |
CD109
|
CD109 molecule |
| chr1_-_44497118 | 2.83 |
ENST00000537678.1
ENST00000466926.1 |
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
| chr17_+_8213539 | 2.82 |
ENST00000583529.1
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
| chr7_-_107642348 | 2.80 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr1_+_110453514 | 2.79 |
ENST00000369802.3
ENST00000420111.2 |
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr19_-_52227221 | 2.77 |
ENST00000222115.1
ENST00000540069.2 |
HAS1
|
hyaluronan synthase 1 |
| chr3_-_9291063 | 2.77 |
ENST00000383836.3
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3 |
| chr4_-_168155730 | 2.76 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr1_-_37499726 | 2.75 |
ENST00000373091.3
ENST00000373093.4 |
GRIK3
|
glutamate receptor, ionotropic, kainate 3 |
| chr3_-_52479043 | 2.74 |
ENST00000231721.2
ENST00000475739.1 |
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G |
| chr1_+_110453109 | 2.73 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr20_+_43343886 | 2.73 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr6_-_53530474 | 2.73 |
ENST00000370905.3
|
KLHL31
|
kelch-like family member 31 |
| chr10_+_123923105 | 2.72 |
ENST00000368999.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr11_-_18813353 | 2.71 |
ENST00000358540.2
ENST00000396171.4 ENST00000396167.2 |
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
| chr12_-_16761117 | 2.71 |
ENST00000538051.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr12_-_71533055 | 2.69 |
ENST00000552128.1
|
TSPAN8
|
tetraspanin 8 |
| chr7_+_73442102 | 2.69 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
| chr8_-_134309335 | 2.68 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
| chr8_-_143696833 | 2.68 |
ENST00000356613.2
|
ARC
|
activity-regulated cytoskeleton-associated protein |
| chr16_+_82660560 | 2.68 |
ENST00000268613.10
ENST00000565636.1 ENST00000431540.3 ENST00000428848.3 |
CDH13
|
cadherin 13 |
| chr2_-_218843623 | 2.68 |
ENST00000413280.1
|
TNS1
|
tensin 1 |
| chr19_+_57019212 | 2.67 |
ENST00000308031.5
ENST00000591537.1 |
ZNF471
|
zinc finger protein 471 |
| chr14_+_105047478 | 2.63 |
ENST00000410013.1
|
C14orf180
|
chromosome 14 open reading frame 180 |
| chr1_-_171621815 | 2.62 |
ENST00000037502.6
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response |
| chr2_-_27341765 | 2.62 |
ENST00000405600.1
|
CGREF1
|
cell growth regulator with EF-hand domain 1 |
| chr12_-_85306562 | 2.61 |
ENST00000551612.1
ENST00000450363.3 ENST00000552192.1 |
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
| chrX_-_71933888 | 2.60 |
ENST00000373542.4
ENST00000339490.3 ENST00000541944.1 ENST00000373539.3 ENST00000373545.3 |
PHKA1
|
phosphorylase kinase, alpha 1 (muscle) |
| chr22_+_32439019 | 2.59 |
ENST00000266088.4
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
| chr5_-_149669192 | 2.58 |
ENST00000398376.3
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr17_-_74533963 | 2.58 |
ENST00000293230.5
|
CYGB
|
cytoglobin |
| chr8_+_61969714 | 2.56 |
ENST00000522621.1
|
CLVS1
|
clavesin 1 |
| chr2_-_238499337 | 2.55 |
ENST00000411462.1
ENST00000409822.1 |
RAB17
|
RAB17, member RAS oncogene family |
| chr1_+_210406121 | 2.54 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr20_+_43343517 | 2.54 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr19_+_30719410 | 2.52 |
ENST00000585628.1
ENST00000591488.1 |
ZNF536
|
zinc finger protein 536 |
| chr3_-_58613323 | 2.52 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr14_-_54420133 | 2.52 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr1_-_85930246 | 2.51 |
ENST00000426972.3
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr20_+_10199566 | 2.51 |
ENST00000430336.1
|
SNAP25
|
synaptosomal-associated protein, 25kDa |
| chr5_-_146889619 | 2.50 |
ENST00000343218.5
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chrX_-_119445263 | 2.49 |
ENST00000309720.5
|
TMEM255A
|
transmembrane protein 255A |
| chr3_+_174577070 | 2.48 |
ENST00000454872.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
| chr13_-_37494365 | 2.47 |
ENST00000350148.5
|
SMAD9
|
SMAD family member 9 |
| chr2_-_27341966 | 2.47 |
ENST00000402394.1
ENST00000402550.1 ENST00000260595.5 |
CGREF1
|
cell growth regulator with EF-hand domain 1 |
| chr5_+_52285144 | 2.46 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
| chr11_-_79151695 | 2.45 |
ENST00000278550.7
|
TENM4
|
teneurin transmembrane protein 4 |
| chrX_+_113818545 | 2.43 |
ENST00000371951.1
ENST00000276198.1 ENST00000371950.3 |
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
| chr1_-_75139397 | 2.43 |
ENST00000326665.5
|
C1orf173
|
chromosome 1 open reading frame 173 |
| chr11_-_107582775 | 2.42 |
ENST00000305991.2
|
SLN
|
sarcolipin |
| chr11_-_89224638 | 2.41 |
ENST00000535633.1
ENST00000263317.4 |
NOX4
|
NADPH oxidase 4 |
| chr4_-_46996424 | 2.40 |
ENST00000264318.3
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
| chr15_+_33603147 | 2.40 |
ENST00000415757.3
ENST00000389232.4 |
RYR3
|
ryanodine receptor 3 |
| chr1_+_110453462 | 2.39 |
ENST00000488198.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
| chr4_-_142054590 | 2.39 |
ENST00000306799.3
|
RNF150
|
ring finger protein 150 |
| chr11_-_89224508 | 2.38 |
ENST00000525196.1
|
NOX4
|
NADPH oxidase 4 |
| chr13_-_37494391 | 2.37 |
ENST00000379826.4
|
SMAD9
|
SMAD family member 9 |
| chr5_-_142077569 | 2.36 |
ENST00000407758.1
ENST00000441680.2 ENST00000419524.2 |
FGF1
|
fibroblast growth factor 1 (acidic) |
| chr1_+_209757051 | 2.35 |
ENST00000009105.1
ENST00000423146.1 ENST00000361322.2 |
CAMK1G
|
calcium/calmodulin-dependent protein kinase IG |
| chrX_-_119445306 | 2.35 |
ENST00000371369.4
ENST00000440464.1 ENST00000519908.1 |
TMEM255A
|
transmembrane protein 255A |
| chr17_+_37782955 | 2.34 |
ENST00000580825.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr4_+_41361616 | 2.33 |
ENST00000513024.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr15_+_96875657 | 2.33 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr11_+_131240373 | 2.33 |
ENST00000374791.3
ENST00000436745.1 |
NTM
|
neurotrimin |
Network of associatons between targets according to the STRING database.
First level regulatory network of EPAS1_BCL3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 11.6 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 2.9 | 8.6 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 2.2 | 11.2 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 2.1 | 17.1 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 1.9 | 5.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.7 | 5.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.7 | 13.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.6 | 7.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.6 | 4.7 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 1.5 | 7.7 | GO:0030070 | insulin processing(GO:0030070) |
| 1.5 | 4.5 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 1.3 | 3.8 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) uterine wall breakdown(GO:0042704) positive regulation of catagen(GO:0051795) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.2 | 4.9 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
| 1.2 | 7.4 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.2 | 6.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 1.2 | 2.4 | GO:0072197 | ureter morphogenesis(GO:0072197) |
| 1.2 | 5.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.2 | 10.4 | GO:0021564 | vagus nerve development(GO:0021564) |
| 1.0 | 7.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 1.0 | 4.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.0 | 1.0 | GO:0032095 | regulation of response to food(GO:0032095) |
| 1.0 | 2.9 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.9 | 3.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.9 | 14.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.9 | 2.6 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.9 | 3.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.8 | 2.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.8 | 7.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 | 2.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.8 | 9.5 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.8 | 4.0 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.8 | 3.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.8 | 3.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 | 7.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.7 | 2.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 | 0.7 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.7 | 4.8 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.7 | 2.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.7 | 4.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 | 5.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.7 | 2.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.6 | 1.9 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.6 | 1.9 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.6 | 7.3 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.6 | 2.4 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.6 | 1.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.6 | 2.9 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.6 | 2.3 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.6 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 2.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.6 | 5.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.6 | 8.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.6 | 13.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 | 3.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.5 | 2.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.5 | 4.8 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 0.5 | 5.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 2.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.5 | 3.0 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.5 | 11.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.5 | 15.1 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.5 | 1.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.5 | 1.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.5 | 3.7 | GO:0060677 | ureteric bud elongation(GO:0060677) |
| 0.5 | 6.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.5 | 0.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.4 | 8.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 | 1.3 | GO:0032880 | regulation of protein localization(GO:0032880) |
| 0.4 | 1.7 | GO:0048686 | modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.4 | 3.0 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.4 | 1.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.4 | 0.4 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.4 | 2.0 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.4 | 5.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.4 | 3.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.4 | 2.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 | 1.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 1.6 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.4 | 7.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.4 | 1.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.4 | 3.9 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.4 | 4.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.4 | 1.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 | 4.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.4 | 4.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 | 1.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.4 | 3.7 | GO:0015820 | leucine transport(GO:0015820) |
| 0.4 | 1.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 | 2.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.4 | 1.1 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.3 | 5.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 | 12.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 | 6.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 | 4.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.3 | 1.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.3 | 2.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.3 | 12.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.3 | 1.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.3 | 1.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 | 5.0 | GO:0035878 | nail development(GO:0035878) |
| 0.3 | 3.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.3 | 1.5 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.3 | 9.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.3 | 7.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 | 0.6 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.3 | 1.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 | 3.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.3 | 1.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.3 | 1.5 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.3 | 1.7 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 | 2.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.3 | 3.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 2.0 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.3 | 0.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 | 5.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.3 | 1.1 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.3 | 3.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 | 3.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.3 | 1.3 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.3 | 2.1 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.3 | 0.5 | GO:0006473 | protein acetylation(GO:0006473) |
| 0.3 | 1.0 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.3 | 6.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 1.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 | 0.8 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 | 1.7 | GO:0014826 | cellular magnesium ion homeostasis(GO:0010961) vein smooth muscle contraction(GO:0014826) |
| 0.2 | 0.7 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.2 | 0.7 | GO:0006173 | dADP biosynthetic process(GO:0006173) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.2 | 1.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 1.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.2 | 1.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.2 | 1.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 | 2.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 2.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.2 | 0.9 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 | 3.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 10.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 3.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.2 | 3.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.2 | 13.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.2 | 0.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.2 | 1.1 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.2 | 1.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) negative regulation of muscle hyperplasia(GO:0014740) |
| 0.2 | 1.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 2.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.2 | 12.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 | 4.4 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 2.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.2 | 4.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 0.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 | 1.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 1.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 1.6 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 | 0.6 | GO:0060319 | coronary vein morphogenesis(GO:0003169) primitive erythrocyte differentiation(GO:0060319) cardiac vascular smooth muscle cell development(GO:0060948) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.2 | 1.6 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 1.0 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.2 | 2.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 0.9 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.2 | 3.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 2.8 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.2 | 2.2 | GO:1902866 | negative regulation of excitatory postsynaptic potential(GO:0090394) regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 | 1.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 2.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.2 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 0.7 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 0.5 | GO:2001054 | regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.2 | 0.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 | 3.8 | GO:0007602 | phototransduction(GO:0007602) |
| 0.2 | 20.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.2 | 1.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 1.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 1.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.2 | 0.7 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.2 | 1.3 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.2 | 2.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 | 1.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 | 2.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 | 2.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 3.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 14.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 0.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 1.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 0.4 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 2.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 0.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 2.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 2.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.1 | 3.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 1.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 1.2 | GO:0050821 | protein stabilization(GO:0050821) |
| 0.1 | 5.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 | 0.4 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.1 | 1.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.8 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.1 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 1.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 | 2.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.7 | GO:0022602 | ovulation cycle process(GO:0022602) |
| 0.1 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 1.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 1.8 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.1 | 1.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 5.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 1.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 1.3 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 | 6.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 0.9 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 | 4.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 1.9 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.9 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.1 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 1.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 7.0 | GO:0008542 | visual learning(GO:0008542) |
| 0.1 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.1 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.1 | 1.7 | GO:0021756 | striatum development(GO:0021756) |
| 0.1 | 3.5 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 0.2 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 | 0.5 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 0.1 | 1.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 2.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 1.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 1.6 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.5 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 | 3.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.1 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 5.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 7.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 4.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 3.8 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 1.5 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.6 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.1 | 0.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.1 | 4.4 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.1 | 0.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 3.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.1 | 0.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.1 | 1.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 1.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 4.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 | 0.3 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.1 | 2.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 2.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 2.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 1.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.5 | GO:0033563 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) dorsal/ventral axon guidance(GO:0033563) |
| 0.1 | 0.5 | GO:0008544 | epidermis development(GO:0008544) |
| 0.1 | 2.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.1 | 1.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.1 | 2.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.1 | 1.7 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
| 0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 1.3 | GO:0009790 | embryo development(GO:0009790) |
| 0.1 | 0.2 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.8 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 1.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 1.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 2.0 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 3.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.1 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.1 | 2.5 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.1 | 0.1 | GO:2001303 | regulation of engulfment of apoptotic cell(GO:1901074) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 | 0.5 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 0.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 | 1.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.1 | 1.8 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.1 | 2.6 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.1 | 2.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.9 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 | 1.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
| 0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 7.9 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.1 | 0.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.1 | 1.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 4.2 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.8 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 | 3.1 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 6.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 1.0 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 1.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 2.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 0.4 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.1 | 1.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 0.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 2.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 1.0 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.1 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 | 2.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.4 | GO:2000181 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.1 | 0.1 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 0.1 | 2.9 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 4.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 6.0 | GO:0001764 | neuron migration(GO:0001764) |
| 0.1 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 1.7 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
| 0.0 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.0 | 0.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.4 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.0 | 0.2 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.0 | 0.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 | 0.8 | GO:0014870 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 1.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.0 | 5.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 | 0.5 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 2.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 2.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 | 0.3 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.0 | 3.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.9 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.0 | 0.6 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 1.1 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 1.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.8 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.0 | 0.5 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
| 0.0 | 1.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.0 | 1.3 | GO:0009799 | specification of symmetry(GO:0009799) |
| 0.0 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.9 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 | 1.0 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.1 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 1.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 5.1 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 | 1.9 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 1.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.0 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) regulation of rubidium ion transport(GO:2000680) |
| 0.0 | 0.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 3.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.0 | 1.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 | 1.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.0 | 0.1 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.0 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.1 | GO:0050976 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 1.5 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.0 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 | 1.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 1.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 1.8 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 0.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.3 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.0 | 1.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 0.9 | GO:0007586 | digestion(GO:0007586) |
| 0.0 | 1.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.0 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 0.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.0 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 | 1.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.0 | 0.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 0.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.7 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.0 | 0.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.0 | 2.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 1.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 1.3 | GO:0097581 | lamellipodium organization(GO:0097581) |
| 0.0 | 1.7 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.0 | 0.1 | GO:0032472 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.0 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 | 0.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 | 1.7 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 2.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.6 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 5.2 | GO:0001558 | regulation of cell growth(GO:0001558) |
| 0.0 | 1.1 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.0 | 1.6 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.0 | 0.6 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.0 | 0.5 | GO:0051259 | protein oligomerization(GO:0051259) |
| 0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 1.0 | GO:0055001 | muscle cell development(GO:0055001) |
| 0.0 | 1.2 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.0 | 2.0 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
| 0.0 | 1.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 9.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.3 | 11.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.6 | 17.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.6 | 11.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.9 | 2.8 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.9 | 6.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.8 | 6.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.8 | 4.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.7 | 2.0 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.6 | 17.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.6 | 9.4 | GO:0005883 | neurofilament(GO:0005883) |
| 0.5 | 1.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 11.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.5 | 1.5 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.5 | 15.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.5 | 2.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.4 | 2.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.4 | 4.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 1.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 5.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.4 | 1.1 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.4 | 1.5 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.4 | 5.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.4 | 2.9 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 3.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 1.0 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.3 | 0.3 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.3 | 6.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.3 | 2.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 9.1 | GO:0031045 | dense core granule(GO:0031045) |
| 0.3 | 10.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 2.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 0.8 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.2 | 0.7 | GO:0001534 | radial spoke(GO:0001534) |
| 0.2 | 0.7 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 1.8 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.2 | 2.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.2 | 2.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 5.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 4.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 0.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.2 | 4.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 0.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 7.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 0.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.2 | 23.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 37.4 | GO:0043204 | perikaryon(GO:0043204) |
| 0.2 | 1.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.2 | 2.9 | GO:0097433 | dense body(GO:0097433) |
| 0.2 | 2.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 1.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.2 | 7.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 8.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.2 | 5.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 4.3 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 0.8 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.2 | 0.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.2 | 0.9 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 3.0 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 14.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.1 | 9.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.1 | 5.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 1.7 | GO:0033643 | host cell part(GO:0033643) |
| 0.1 | 4.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 4.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 2.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 4.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 2.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 2.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 28.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 5.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.1 | 57.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 9.7 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 2.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 8.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 1.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.1 | 0.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 3.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.1 | 15.8 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 2.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.5 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 1.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.1 | 6.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 2.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 5.9 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 3.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 2.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 1.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 14.7 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 7.9 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 15.5 | GO:0045202 | synapse(GO:0045202) |
| 0.1 | 1.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 1.1 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 1.9 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 19.0 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.1 | 3.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 1.8 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 1.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 1.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 6.9 | GO:0036477 | somatodendritic compartment(GO:0036477) |
| 0.0 | 10.5 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 15.2 | GO:0030425 | dendrite(GO:0030425) |
| 0.0 | 1.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 4.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 1.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 1.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 2.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 3.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 2.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.0 | 5.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
| 0.0 | 3.6 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 9.4 | GO:0043005 | neuron projection(GO:0043005) |
| 0.0 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 0.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 1.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 15.8 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 2.9 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 1.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 1.0 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 1.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 3.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 2.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 8.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 1.7 | 8.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.7 | 13.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 1.3 | 8.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 1.2 | 3.7 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.2 | 7.4 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 1.2 | 4.8 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 1.2 | 7.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 1.1 | 4.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 1.0 | 9.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.0 | 8.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 1.0 | 3.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 1.0 | 5.8 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.9 | 3.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.9 | 13.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.8 | 4.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.8 | 8.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.8 | 5.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.7 | 6.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.7 | 2.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.7 | 2.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.7 | 2.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.7 | 5.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.6 | 1.9 | GO:0070698 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) type I activin receptor binding(GO:0070698) |
| 0.6 | 1.9 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.6 | 3.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.6 | 3.0 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.6 | 2.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.6 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.6 | 2.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.6 | 8.0 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.5 | 3.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.5 | 1.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.5 | 3.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.5 | 15.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.5 | 9.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.5 | 1.5 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.5 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.5 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.5 | 1.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.5 | 2.3 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.5 | 1.4 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.4 | 3.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.4 | 15.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.4 | 3.0 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.4 | 4.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.4 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 1.5 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.4 | 1.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.4 | 1.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.4 | 3.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 15.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 3.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.4 | 3.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.4 | 2.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.4 | 2.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 12.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.4 | 1.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.3 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 6.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 1.0 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.3 | 3.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 1.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.3 | 5.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.3 | 1.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.3 | 21.6 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.3 | 2.9 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.3 | 11.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.3 | 5.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.3 | 1.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.3 | 0.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.3 | 1.5 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.3 | 1.8 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.3 | 1.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.3 | 2.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.3 | 1.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.3 | 2.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 6.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.3 | 22.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.3 | 1.6 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.3 | 5.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.3 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.3 | 0.8 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 2.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 4.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.3 | 1.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.2 | 11.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 0.7 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.2 | 4.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 2.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.2 | 2.2 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 1.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 7.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 5.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.2 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 0.7 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.2 | 3.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 9.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 2.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 3.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 12.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 0.6 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 3.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 1.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.2 | 2.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.2 | 3.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.2 | 4.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 1.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 10.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.2 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 3.1 | GO:0036122 | BMP binding(GO:0036122) |
| 0.2 | 5.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.2 | 1.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.2 | 0.9 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.2 | 0.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 2.4 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 3.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 5.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.2 | 2.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.2 | 1.0 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.2 | 22.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.2 | 1.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 6.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 2.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.2 | 3.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.2 | 1.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.2 | 3.5 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.2 | 1.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.2 | 7.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.2 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.2 | 3.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 4.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 0.6 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.1 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 1.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.1 | 6.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.1 | 3.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 5.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 1.8 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 0.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 2.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.1 | 1.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 3.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 16.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 1.7 | GO:0015232 | xenobiotic-transporting ATPase activity(GO:0008559) heme transporter activity(GO:0015232) |
| 0.1 | 4.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 3.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 3.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.9 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.1 | 7.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 9.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 2.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.6 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.1 | 1.3 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.1 | 3.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 1.2 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 4.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 5.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.4 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.1 | 2.3 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 3.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 2.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 2.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 15.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 1.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.1 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 1.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 7.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 3.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 6.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.1 | 7.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 6.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 2.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 4.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 6.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 4.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 2.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.3 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.1 | 0.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.1 | 2.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 10.9 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 3.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 1.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 3.8 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 17.8 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 1.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 2.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.0 | 1.6 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.0 | 1.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 3.5 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 3.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 1.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 1.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.0 | 1.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.1 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.0 | 0.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.0 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.0 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 2.7 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.1 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.0 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.1 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.0 | 1.4 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.8 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.8 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.0 | 0.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 1.1 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 2.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 5.2 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.0 | 0.2 | GO:0008092 | cytoskeletal protein binding(GO:0008092) |
| 0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 10.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 15.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 17.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 5.1 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 1.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 6.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 62.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 7.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 7.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 12.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 13.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 7.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 12.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 11.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 8.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 7.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 7.2 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 4.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 7.3 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 3.5 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 7.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 6.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 3.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 5.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 24.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 3.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 1.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 3.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 2.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 4.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 2.0 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.0 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 1.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 2.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 8.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 1.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 11.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.7 | 11.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.4 | 22.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.4 | 8.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.4 | 5.3 | REACTOME OPSINS | Genes involved in Opsins |
| 0.3 | 7.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.3 | 14.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.3 | 15.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 6.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 9.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 6.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 10.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.2 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 2.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 6.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 14.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.2 | 3.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 0.9 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
| 0.2 | 5.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 6.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 4.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 5.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 4.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 10.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.1 | 6.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 3.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 2.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 2.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 4.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 3.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 3.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 0.1 | 2.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 4.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 3.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 1.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 4.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 4.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 2.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 3.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 2.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 4.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 3.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 3.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 3.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 5.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 9.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 1.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 2.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 2.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 1.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 7.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 1.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 3.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.0 | 2.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 0.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 1.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 1.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 1.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 1.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.9 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 6.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 2.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 1.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 1.6 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.0 | 2.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |